Kaat Schroven

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Pseudomonas Aeruginosa

Combination Therapy

Acute Kidney Injury

Top Venues

Microbiology spectrum

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Eveline-Marie Lammens, Daniel Christophe Volke, Kaat Schroven, Marleen Voet, Alison Kerremans, Rob Lavigne, Hanne Hendrix
A SEVA-based, CRISPR-Cas3-assisted genome engineering approach for Pseudomonas with efficient vector curing. Microbiology spectrum (2023)
Kaat Schroven, Leena Putzeys, Alison Kerremans, Pieter-Jan Ceyssens, Marta Vallino, Jan Paeshuyse, Farhana Haque, Ahmed Yusuf, Matthias D Koch, Rob Lavigne
The phage-encoded PIT4 protein affects multiple two-component systems of Pseudomonas aeruginosa . Microbiology spectrum (2023)
Brieuc Van Nieuwenhuyse, Dimitri Van der Linden, Olga Chatzis, Cédric Lood, Jeroen Wagemans, Rob Lavigne, Kaat Schroven, Jan Paeshuyse, Catherine de Magnée, Etienne Sokal, Xavier Stéphenne, Isabelle Scheers, Hector Rodriguez-Villalobos, Sarah Djebara, Maya Merabishvili, Patrick Soentjens, Jean-Paul Pirnay
Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler. Nature communications 13 (1) (2022)